CHEBI:167574 - semaglutide

Main ChEBI Ontology Automatic Xrefs Reactions Pathways Models
ChEBI Name semaglutide
ChEBI ID CHEBI:167574
Definition A polypeptide that contains a linear sequence of 31 amino acids joined together by peptide linkages. It is an agonist of glucagon-like peptide-1 receptors (GLP-1 AR) and used for the treatment of type 2 diabetes.
Stars This entity has been manually annotated by the ChEBI Team.
Supplier Information
Download Molfile XML SDF
more structures >>
Wikipedia License
Waiting for wikipedia content
Read full article at Wikipedia
Formula C187H291N45O59
Net Charge 0
Average Mass 4113.641
Monoisotopic Mass 4111.11538
InChI InChI=1S/C187H291N45O59/c1-18-105(10)154(180(282)208-108(13)159(261)216-133(86-114-89-200-119-50-40-39-49-117(114)119)170(272)218-129(82-102(4)5)171(273)228-152(103(6)7)178(280)215-121(53-44-72-199-186(192)193)162(264)201-91-141(242)209-120(52-43-71-198-185(190)191)161(263)204-94-151(257)258)230-172(274)131(83-111-45-33-31-34-46-111)219-167(269)126(64-69-149(253)254)214-166(268)122(51-41-42-70-195-144(245)98-290-79-78-289-76-74-197-145(246)99-291-80-77-288-75-73-196-139(240)66-61-127(183(285)286)211-140(241)54-37-29-27-25-23-21-19-20-22-24-26-28-30-38-55-146(247)248)212-158(260)107(12)206-157(259)106(11)207-165(267)125(60-65-138(189)239)210-142(243)92-202-163(265)123(62-67-147(249)250)213-168(270)128(81-101(2)3)217-169(271)130(85-113-56-58-116(238)59-57-113)220-175(277)135(95-233)223-177(279)137(97-235)224-179(281)153(104(8)9)229-174(276)134(88-150(255)256)221-176(278)136(96-234)225-182(284)156(110(15)237)231-173(275)132(84-112-47-35-32-36-48-112)222-181(283)155(109(14)236)227-143(244)93-203-164(266)124(63-68-148(251)252)226-184(287)187(16,17)232-160(262)118(188)87-115-90-194-100-205-115/h31-36,39-40,45-50,56-59,89-90,100-110,118,120-137,152-156,200,233-238H,18-30,37-38,41-44,51-55,60-88,91-99,188H2,1-17H3,(H2,189,239)(H,194,205)(H,195,245)(H,196,240)(H,197,246)(H,201,264)(H,202,265)(H,203,266)(H,204,263)(H,206,259)(H,207,267)(H,208,282)(H,209,242)(H,210,243)(H,211,241)(H,212,260)(H,213,270)(H,214,268)(H,215,280)(H,216,261)(H,217,271)(H,218,272)(H,219,269)(H,220,277)(H,221,278)(H,222,283)(H,223,279)(H,224,281)(H,225,284)(H,226,287)(H,227,244)(H,228,273)(H,229,276)(H,230,274)(H,231,275)(H,232,262)(H,247,248)(H,249,250)(H,251,252)(H,253,254)(H,255,256)(H,257,258)(H,285,286)(H4,190,191,198)(H4,192,193,199)/t105-,106-,107-,108-,109+,110+,118-,120-,121-,122-,123-,124-,125-,126-,127+,128-,129-,130-,131-,132-,133-,134-,135-,136-,137-,152-,153-,154-,155-,156-/m0/s1
InChIKey DLSWIYLPEUIQAV-CCUURXOWSA-N
SMILES CC[C@H](C)[C@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCCNC(=O)COCCOCCNC(=O)COCCOCCNC(=O)CC[C@@H](NC(=O)CCCCCCCCCCCCCCCCC(O)=O)C(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC1=CC=C(O)C=C1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)C(C)(C)NC(=O)[C@@H](N)CC1=CN=CN1)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(O)=O
Roles Classification
Chemical Role(s): Bronsted base
A molecular entity capable of accepting a hydron from a donor (Bronsted acid).
(via organic amino compound )
Biological Role(s): glucagon-like peptide-1 receptor agonist
An agonist that binds to and activates glucagon-like peptide-1 (GLP-1) receptors.
anti-obesity agent
Any substance which is used to reduce or control weight.
Application(s): appetite depressant
Agent that is used to decrease appetite.
hypoglycemic agent
A drug which lowers the blood glucose level.
neuroprotective agent
Any compound that can be used for the treatment of neurodegenerative disorders.
View more via ChEBI Ontology
ChEBI Ontology
Outgoing semaglutide (CHEBI:167574) has role anti-obesity agent (CHEBI:74518)
semaglutide (CHEBI:167574) has role appetite depressant (CHEBI:50507)
semaglutide (CHEBI:167574) has role glucagon-like peptide-1 receptor agonist (CHEBI:71196)
semaglutide (CHEBI:167574) has role hypoglycemic agent (CHEBI:35526)
semaglutide (CHEBI:167574) has role neuroprotective agent (CHEBI:63726)
semaglutide (CHEBI:167574) is a lipopeptide (CHEBI:46895)
semaglutide (CHEBI:167574) is a polypeptide (CHEBI:15841)
IUPAC Name
L-histidyl-2-methylalanyl-L-α-glutamylglycyl-L-threonyl-L-phenylalanyl-L-threonyl-L-seryl-L-α-aspartyl-L-valyl-L-seryl-L-seryl-L-tyrosyl-L-leucyl-L-α-glutamylglycyl-L-glutaminyl-L-alanyl-L-alanyl-N6-((N-(17-carboxyheptadecanoyl)-D-γ-glutamyl)amino-10-oxo-3,6,12,15-tetraoxa-9-azaheptadecanan-1-oyl)-L-lysyl-L-α-glutamyl-L-phenylalanyl-L-isoleucyl-L-alanyl-L-tryptophyl-L-leucyl-L-valyl-L-arginylglycyl-L-arginylglycine
Synonyms Sources
NN 9535 ChemIDplus
NN-9535 DrugBank
NN9535 ChemIDplus
NNC 0113-0217 ChemIDplus
NNC-0113-0217 DrugBank
Brand Names Sources
Ozempic KEGG DRUG
Rybelsus ChEBI
Manual Xrefs Databases
34981134 ChemSpider
D10025 KEGG DRUG
DB13928 DrugBank
Semaglutide Wikipedia
View more database links
Registry Number Type Source
910463-68-2 CAS Registry Number ChemIDplus
Citations Waiting for Citations Types Sources
24608440 PubMed citation Europe PMC
29431519 PubMed citation Europe PMC
30741689 PubMed citation Europe PMC
31305048 PubMed citation Europe PMC
31486321 PubMed citation Europe PMC
31770356 PubMed citation Europe PMC
31801807 PubMed citation Europe PMC
31952996 PubMed citation Europe PMC
31975761 PubMed citation Europe PMC
32232400 PubMed citation Europe PMC
32476529 PubMed citation Europe PMC
32890462 PubMed citation Europe PMC
32921892 PubMed citation Europe PMC
33074557 PubMed citation Europe PMC
33108617 PubMed citation Europe PMC
33159658 PubMed citation Europe PMC
33179892 PubMed citation Europe PMC
33185364 PubMed citation Europe PMC
33222922 PubMed citation Europe PMC
33257834 PubMed citation Europe PMC
33354706 PubMed citation Europe PMC
33363667 PubMed citation Europe PMC
33417950 PubMed citation Europe PMC
33439580 PubMed citation Europe PMC
33439583 PubMed citation Europe PMC
33447122 PubMed citation Europe PMC
33565043 PubMed citation Europe PMC
33567185 PubMed citation Europe PMC
33591618 PubMed citation Europe PMC
33615400 PubMed citation Europe PMC
33627989 PubMed citation Europe PMC
33627997 PubMed citation Europe PMC
Last Modified
28 февраля 2021